Cite
MLA Citation
Eoghan M. McCarthy et al.. “The potential overlapping populations for treatment with belimumab and rituximab using current NHS England and National Institute for Health and Care Excellence Guidelines in England and Wales.” Rheumatology, vol. 56, 2017, pp. 1041–1043. http://access.bl.uk/ark:/81055/vdc_100109734127.0x000013